Free Trial

Aimia (AIM) Competitors

Aimia logo
C$2.60 +0.09 (+3.59%)
As of 01:24 PM Eastern

AIM vs. CRON, TEV, ABT, NOT, PYR, TLRY, SLS, NVO, DNA, and VBV

Should you be buying Aimia stock or one of its competitors? The main competitors of Aimia include Cronos Group (CRON), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Tilray Brands (TLRY), Solaris Resources (SLS), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), and VBI Vaccines (VBV). These companies are all part of the "pharmaceutical products" industry.

Aimia vs.

Aimia (TSE:AIM) and Cronos Group (TSE:CRON) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, community ranking, dividends, media sentiment and earnings.

Aimia received 320 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 54.18% of users gave Aimia an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

CompanyUnderperformOutperform
AimiaOutperform Votes
389
54.18%
Underperform Votes
329
45.82%
Cronos GroupOutperform Votes
69
50.74%
Underperform Votes
67
49.26%

Aimia has a net margin of -16.96% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -4.40% beat Aimia's return on equity.

Company Net Margins Return on Equity Return on Assets
Aimia-16.96% -14.38% -4.93%
Cronos Group -42.65%-4.40%-3.73%

Aimia currently has a consensus target price of C$4.00, suggesting a potential upside of 53.85%. Cronos Group has a consensus target price of C$3.54, suggesting a potential upside of 37.74%. Given Aimia's stronger consensus rating and higher probable upside, equities research analysts plainly believe Aimia is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aimia
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

31.6% of Aimia shares are owned by institutional investors. Comparatively, 16.0% of Cronos Group shares are owned by institutional investors. 3.3% of Aimia shares are owned by insiders. Comparatively, 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Aimia has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

Cronos Group has lower revenue, but higher earnings than Aimia. Cronos Group is trading at a lower price-to-earnings ratio than Aimia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AimiaC$464.71M0.54-C$78.81M-C$0.81-3.20
Cronos GroupC$76.86M8.83-C$32.78M-C$0.18-14.30

In the previous week, Aimia's average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.

Company Overall Sentiment
Aimia Neutral
Cronos Group Neutral

Summary

Aimia beats Cronos Group on 9 of the 16 factors compared between the two stocks.

Remove Ads
Get Aimia News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIM vs. The Competition

MetricAimiaAsset Management IndustryFinancial SectorTSE Exchange
Market CapC$250.06MC$1.14BC$4.22BC$5.62B
Dividend Yield33.90%4.42%4.19%6.83%
P/E Ratio-3.2026.9315.9630.44
Price / Sales0.542,260.791,696.18612.64
Price / Cash0.5160.8148.9782.93
Price / Book0.451.113.353.62
Net Income-C$78.81MC$259.01MC$1.28BC$299.15M
7 Day Performance8.33%-0.36%-0.04%-0.90%
1 Month Performance4.00%-2.34%6.21%-0.17%
1 Year Performance1.56%4.03%9.90%14.57%

Aimia Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIM
Aimia
1.5071 of 5 stars
C$2.60
+3.6%
C$4.00
+53.8%
-3.8%C$250.06MC$464.71M-3.2020High Trading Volume
CRON
Cronos Group
N/AC$2.69
-0.4%
C$3.54
+31.6%
-28.7%C$710.33MC$76.86M-14.97450
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
TLRY
Tilray Brands
N/AC$0.92
+4.5%
N/A-70.0%C$592.82MC$610.34M-2.222,650
SLS
Solaris Resources
1.2219 of 5 stars
C$5.16
+4.5%
C$13.50
+161.6%
+7.2%C$591.93MN/A-8.9910News Coverage
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
Remove Ads

Related Companies and Tools


This page (TSE:AIM) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners